HAPPY EASTER! 50% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s

Information

88 Sidney Street, 2nd Floor

Cambridge MA 02139-4169

617 649 8600

www.agios.com

Industry: Biotechnology

Sector: Healthcare

Agios Pharmaceuticals

Description

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Click to get the best stock tips daily for free!
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
F
FNA
$12.99
0.85% Apr 15
V
VCSH
$78.34
0.370% Apr 15
F
FTSM
$59.85
0.117% Apr 15
S
SLQD
$49.97
0.260% Apr 15
I
ISTB
$48.11
0.239% Apr 15

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE